Quebec assessment of COVID-19 of April 1, 2021 | COVID-19 | News | The Nouvelliste

Quebec assessment of COVID-19 of April 1, 2021 | COVID-19 | News | The Nouvelliste
Quebec assessment of COVID-19 of April 1, 2021 | COVID-19 | News | The Nouvelliste
Un total of 312,362 people have been infected since the start of the pandemic? of which 292,648 are considered to be restored? and we deplore 10,676 deaths.

One death has occurred in the past 24 hours, five between March 25 and 30 and three on an unknown date.

There are 487 hospitalizations, an increase of two from Wednesday, and 119 intensive care patients, a decrease of one.

A total of 41,053 samples were taken on March 30.

On the vaccine side, 41,406 doses were administered in the last 24 hours, for a total of 1,391,649, out of 1,652,905 doses received.

In Canada

Across Canada, 985,720 cases of COVID-19 and 22,991 deaths have been reported since the virus first appeared in the country.

Here is the distribution of cases across the country since the start of the pandemic, according to the most recent provincial and territorial reports:

– 352,460 cases in Ontario, including 7,389 deaths;

– 312,362 cases in Quebec, including 10,676 deaths;

– 148,332 cases in Alberta, including 1990 deaths;

– 100,048 cases in British Columbia, including 1,458 deaths;

– 34,122 cases in Manitoba, including 935 deaths;

– 33,590 cases in Saskatchewan, including 436 deaths;

– 1,716 cases in Nova Scotia, including 66 deaths;

– 1,613 cases in New Brunswick, including 30 deaths;

– 1,019 cases in Newfoundland and Labrador, including six deaths;

– 395 cases in Nunavut, including four deaths;

– 159 cases in Prince Edward Island;

– 73 cases in the Yukon, including one death;

– 42 cases in the Northwest Territories.

To these provincial and territorial reports are added the 13 cases, all cured, among passengers repatriated from the Grand Princess cruise ship on March 10, 2020.

Get the latest news delivered to your inbox

Follow us on social media networks

PREV Arthritis medication: the cardiovascular risks of Xeljanz under the microscope
NEXT Increase in hospitalizations related to COVID-19